FDA recall, , Moderate risk
Medic Apheresis Platelets and Platelets Extended Dating
Apheresis Platelets, Leukocytes Reduced, Irradiated, with a platelet count higher than was acceptable, were distributed.
Recall ended Sep 4, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Medic Inc. recalled Apheresis Platelets, Leukocytes Reduced, Irradiated, and Apheresis Platelets, Leukocytes Reduced, Extended Dating, because they had a platelet count higher than was acceptable. The recall began September 24, 2025, and was classified by the FDA on September 4, 2026. The products were distributed in Tennessee.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Platelets Extended Dating
Reason: Apheresis Platelets, Leukocytes Reduced, Extended Dating, with a platelet count higher than was acceptable, were distributed.
Apheresis Platelets, Leukocytes Reduced, Irradiated
Reason: Apheresis Platelets, Leukocytes Reduced, Irradiated, with a platelet count higher than was acceptable, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- Medic Inc
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99456
- Recall numbers
- B-0192-2026, B-0193-2026, B-0232-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
